Cargando…
Rituximab for the treatment of refractory simultaneous anti-glomerular basement membrane (anti-GBM) and membranous nephropathy
Antibody-mediated anti-glomerular basement membrane (anti-GBM) disease occurs rarely in the presence of another B-cell disorder, membranous nephropathy. The coexistence of these two autoimmune disorders would be anticipated to require differing, specific therapies targeted to each disease process. W...
Autores principales: | Bandak, Ghassan, Jones, Bruce A., Li, Jian, Yee, Jerry, Umanath, Kausik |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4389165/ https://www.ncbi.nlm.nih.gov/pubmed/25859351 http://dx.doi.org/10.1093/ckj/sft152 |
Ejemplares similares
-
Rituximab for the treatment of refractory anti-glomerular basement membrane disease
por: Yang, Xue-Fen, et al.
Publicado: (2022) -
Rituximab for Anti–Glomerular Basement Membrane Disease
por: Jain, Rashmi, et al.
Publicado: (2018) -
Educational Case: Necrotizing and Crescentic Glomerulonephritis With Anti-Glomerular Basement Membrane Antibodies (Anti-Gbm)
por: Peyton, Nicole, et al.
Publicado: (2020) -
The Characteristics of Concurrent Anti-Glomerular Basement Membrane Nephritis and Membranous Nephropathy
por: Bu, Lihong, et al.
Publicado: (2023) -
Use of rituximab as an induction therapy in anti-glomerular basement-membrane disease
por: Heitz, M., et al.
Publicado: (2018)